1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Melanoma Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Non-invasive melanoma 1.2.3 Invasive melanoma 1.3 Market by Application 1.3.1 Global Melanoma Cancer Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Cancer Research Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Melanoma Cancer Market Perspective (2016-2027) 2.2 Melanoma Cancer Growth Trends by Regions 2.2.1 Melanoma Cancer Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Melanoma Cancer Historic Market Share by Regions (2016-2021) 2.2.3 Melanoma Cancer Forecasted Market Size by Regions (2022-2027) 2.3 Melanoma Cancer Industry Dynamic 2.3.1 Melanoma Cancer Market Trends 2.3.2 Melanoma Cancer Market Drivers 2.3.3 Melanoma Cancer Market Challenges 2.3.4 Melanoma Cancer Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Melanoma Cancer Players by Revenue 3.1.1 Global Top Melanoma Cancer Players by Revenue (2016-2021) 3.1.2 Global Melanoma Cancer Revenue Market Share by Players (2016-2021) 3.2 Global Melanoma Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Melanoma Cancer Revenue 3.4 Global Melanoma Cancer Market Concentration Ratio 3.4.1 Global Melanoma Cancer Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Melanoma Cancer Revenue in 2020 3.5 Melanoma Cancer Key Players Head office and Area Served 3.6 Key Players Melanoma Cancer Product Solution and Service 3.7 Date of Enter into Melanoma Cancer Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Melanoma Cancer Breakdown Data by Type 4.1 Global Melanoma Cancer Historic Market Size by Type (2016-2021) 4.2 Global Melanoma Cancer Forecasted Market Size by Type (2022-2027) 5 Melanoma Cancer Breakdown Data by Application 5.1 Global Melanoma Cancer Historic Market Size by Application (2016-2021) 5.2 Global Melanoma Cancer Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Melanoma Cancer Market Size (2016-2027) 6.2 North America Melanoma Cancer Market Size by Type 6.2.1 North America Melanoma Cancer Market Size by Type (2016-2021) 6.2.2 North America Melanoma Cancer Market Size by Type (2022-2027) 6.2.3 North America Melanoma Cancer Market Size by Type (2016-2027) 6.3 North America Melanoma Cancer Market Size by Application 6.3.1 North America Melanoma Cancer Market Size by Application (2016-2021) 6.3.2 North America Melanoma Cancer Market Size by Application (2022-2027) 6.3.3 North America Melanoma Cancer Market Size by Application (2016-2027) 6.4 North America Melanoma Cancer Market Size by Country 6.4.1 North America Melanoma Cancer Market Size by Country (2016-2021) 6.4.2 North America Melanoma Cancer Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Melanoma Cancer Market Size (2016-2027) 7.2 Europe Melanoma Cancer Market Size by Type 7.2.1 Europe Melanoma Cancer Market Size by Type (2016-2021) 7.2.2 Europe Melanoma Cancer Market Size by Type (2022-2027) 7.2.3 Europe Melanoma Cancer Market Size by Type (2016-2027) 7.3 Europe Melanoma Cancer Market Size by Application 7.3.1 Europe Melanoma Cancer Market Size by Application (2016-2021) 7.3.2 Europe Melanoma Cancer Market Size by Application (2022-2027) 7.3.3 Europe Melanoma Cancer Market Size by Application (2016-2027) 7.4 Europe Melanoma Cancer Market Size by Country 7.4.1 Europe Melanoma Cancer Market Size by Country (2016-2021) 7.4.2 Europe Melanoma Cancer Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Melanoma Cancer Market Size (2016-2027) 8.2 Asia-Pacific Melanoma Cancer Market Size by Type 8.2.1 Asia-Pacific Melanoma Cancer Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Melanoma Cancer Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Melanoma Cancer Market Size by Type (2016-2027) 8.3 Asia-Pacific Melanoma Cancer Market Size by Application 8.3.1 Asia-Pacific Melanoma Cancer Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Melanoma Cancer Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Melanoma Cancer Market Size by Application (2016-2027) 8.4 Asia-Pacific Melanoma Cancer Market Size by Region 8.4.1 Asia-Pacific Melanoma Cancer Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Melanoma Cancer Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Melanoma Cancer Market Size (2016-2027) 9.2 Latin America Melanoma Cancer Market Size by Type 9.2.1 Latin America Melanoma Cancer Market Size by Type (2016-2021) 9.2.2 Latin America Melanoma Cancer Market Size by Type (2022-2027) 9.2.3 Latin America Melanoma Cancer Market Size by Type (2016-2027) 9.3 Latin America Melanoma Cancer Market Size by Application 9.3.1 Latin America Melanoma Cancer Market Size by Application (2016-2021) 9.3.2 Latin America Melanoma Cancer Market Size by Application (2022-2027) 9.3.3 Latin America Melanoma Cancer Market Size by Application (2016-2027) 9.4 Latin America Melanoma Cancer Market Size by Country 9.4.1 Latin America Melanoma Cancer Market Size by Country (2016-2021) 9.4.2 Latin America Melanoma Cancer Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Melanoma Cancer Market Size (2016-2027) 10.2 Middle East & Africa Melanoma Cancer Market Size by Type 10.2.1 Middle East & Africa Melanoma Cancer Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Melanoma Cancer Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Melanoma Cancer Market Size by Type (2016-2027) 10.3 Middle East & Africa Melanoma Cancer Market Size by Application 10.3.1 Middle East & Africa Melanoma Cancer Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Melanoma Cancer Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Melanoma Cancer Market Size by Application (2016-2027) 10.4 Middle East & Africa Melanoma Cancer Market Size by Country 10.4.1 Middle East & Africa Melanoma Cancer Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Melanoma Cancer Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AB Sciences 11.1.1 AB Sciences Company Details 11.1.2 AB Sciences Business Overview 11.1.3 AB Sciences Melanoma Cancer Introduction 11.1.4 AB Sciences Revenue in Melanoma Cancer Business (2016-2021) 11.1.5 AB Sciences Recent Development 11.2 Incyte 11.2.1 Incyte Company Details 11.2.2 Incyte Business Overview 11.2.3 Incyte Melanoma Cancer Introduction 11.2.4 Incyte Revenue in Melanoma Cancer Business (2016-2021) 11.2.5 Incyte Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Melanoma Cancer Introduction 11.3.4 Merck Revenue in Melanoma Cancer Business (2016-2021) 11.3.5 Merck Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Melanoma Cancer Introduction 11.4.4 Novartis Revenue in Melanoma Cancer Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 Pierre Fabre 11.5.1 Pierre Fabre Company Details 11.5.2 Pierre Fabre Business Overview 11.5.3 Pierre Fabre Melanoma Cancer Introduction 11.5.4 Pierre Fabre Revenue in Melanoma Cancer Business (2016-2021) 11.5.5 Pierre Fabre Recent Development 11.6 Amgen 11.6.1 Amgen Company Details 11.6.2 Amgen Business Overview 11.6.3 Amgen Melanoma Cancer Introduction 11.6.4 Amgen Revenue in Melanoma Cancer Business (2016-2021) 11.6.5 Amgen Recent Development 11.7 AstraZeneca 11.7.1 AstraZeneca Company Details 11.7.2 AstraZeneca Business Overview 11.7.3 AstraZeneca Melanoma Cancer Introduction 11.7.4 AstraZeneca Revenue in Melanoma Cancer Business (2016-2021) 11.7.5 AstraZeneca Recent Development 11.8 Bristol-Myers Squibb 11.8.1 Bristol-Myers Squibb Company Details 11.8.2 Bristol-Myers Squibb Business Overview 11.8.3 Bristol-Myers Squibb Melanoma Cancer Introduction 11.8.4 Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2016-2021) 11.8.5 Bristol-Myers Squibb Recent Development 11.9 Daiichi Sankyo 11.9.1 Daiichi Sankyo Company Details 11.9.2 Daiichi Sankyo Business Overview 11.9.3 Daiichi Sankyo Melanoma Cancer Introduction 11.9.4 Daiichi Sankyo Revenue in Melanoma Cancer Business (2016-2021) 11.9.5 Daiichi Sankyo Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Melanoma Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Non-invasive melanoma Table 3. Key Players of Invasive melanoma Table 4. Global Melanoma Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Melanoma Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Melanoma Cancer Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Melanoma Cancer Market Share by Regions (2016-2021) Table 8. Global Melanoma Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Melanoma Cancer Market Share by Regions (2022-2027) Table 10. Melanoma Cancer Market Trends Table 11. Melanoma Cancer Market Drivers Table 12. Melanoma Cancer Market Challenges Table 13. Melanoma Cancer Market Restraints Table 14. Global Melanoma Cancer Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Melanoma Cancer Market Share by Players (2016-2021) Table 16. Global Top Melanoma Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Cancer as of 2020) Table 17. Ranking of Global Top Melanoma Cancer Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Melanoma Cancer Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Melanoma Cancer Product Solution and Service Table 21. Date of Enter into Melanoma Cancer Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Melanoma Cancer Market Size by Type (2016-2021) (US$ Million) Table 24. Global Melanoma Cancer Revenue Market Share by Type (2016-2021) Table 25. Global Melanoma Cancer Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Melanoma Cancer Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Melanoma Cancer Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Melanoma Cancer Revenue Market Share by Application (2016-2021) Table 29. Global Melanoma Cancer Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Melanoma Cancer Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Melanoma Cancer Market Size by Type (2016-2021) (US$ Million) Table 32. North America Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Melanoma Cancer Market Size by Application (2016-2021) (US$ Million) Table 34. North America Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Melanoma Cancer Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Melanoma Cancer Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Melanoma Cancer Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Melanoma Cancer Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Melanoma Cancer Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Melanoma Cancer Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Melanoma Cancer Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Melanoma Cancer Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Melanoma Cancer Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Melanoma Cancer Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Melanoma Cancer Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Melanoma Cancer Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Melanoma Cancer Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Melanoma Cancer Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Melanoma Cancer Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Melanoma Cancer Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Melanoma Cancer Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Melanoma Cancer Market Size by Country (2022-2027) & (US$ Million) Table 61. AB Sciences Company Details Table 62. AB Sciences Business Overview Table 63. AB Sciences Melanoma Cancer Product Table 64. AB Sciences Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million) Table 65. AB Sciences Recent Development Table 66. Incyte Company Details Table 67. Incyte Business Overview Table 68. Incyte Melanoma Cancer Product Table 69. Incyte Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million) Table 70. Incyte Recent Development Table 71. Merck Company Details Table 72. Merck Business Overview Table 73. Merck Melanoma Cancer Product Table 74. Merck Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million) Table 75. Merck Recent Development Table 76. Novartis Company Details Table 77. Novartis Business Overview Table 78. Novartis Melanoma Cancer Product Table 79. Novartis Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million) Table 80. Novartis Recent Development Table 81. Pierre Fabre Company Details Table 82. Pierre Fabre Business Overview Table 83. Pierre Fabre Melanoma Cancer Product Table 84. Pierre Fabre Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million) Table 85. Pierre Fabre Recent Development Table 86. Amgen Company Details Table 87. Amgen Business Overview Table 88. Amgen Melanoma Cancer Product Table 89. Amgen Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million) Table 90. Amgen Recent Development Table 91. AstraZeneca Company Details Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Melanoma Cancer Product Table 94. AstraZeneca Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million) Table 95. AstraZeneca Recent Development Table 96. Bristol-Myers Squibb Company Details Table 97. Bristol-Myers Squibb Business Overview Table 98. Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million) Table 99. Bristol-Myers Squibb Recent Development Table 100. Daiichi Sankyo Company Details Table 101. Daiichi Sankyo Business Overview Table 102. Daiichi Sankyo Melanoma Cancer Product Table 103. Daiichi Sankyo Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million) Table 104. Daiichi Sankyo Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Melanoma Cancer Market Share by Type: 2020 VS 2027 Figure 2. Non-invasive melanoma Features Figure 3. Invasive melanoma Features Figure 4. Global Melanoma Cancer Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Cancer Research Centers Case Studies Figure 7. Melanoma Cancer Report Years Considered Figure 8. Global Melanoma Cancer Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 9. Global Melanoma Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Melanoma Cancer Market Share by Regions: 2020 VS 2027 Figure 11. Global Melanoma Cancer Market Share by Regions (2022-2027) Figure 12. Global Melanoma Cancer Market Share by Players in 2020 Figure 13. Global Top Melanoma Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Cancer as of 2020 Figure 14. The Top 10 and 5 Players Market Share by Melanoma Cancer Revenue in 2020 Figure 15. Global Melanoma Cancer Revenue Market Share by Type (2016-2021) Figure 16. Global Melanoma Cancer Revenue Market Share by Type (2022-2027) Figure 17. North America Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 18. North America Melanoma Cancer Market Share by Type (2016-2027) Figure 19. North America Melanoma Cancer Market Share by Application (2016-2027) Figure 20. North America Melanoma Cancer Market Share by Country (2016-2027) Figure 21. United States Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. Canada Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Europe Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Melanoma Cancer Market Share by Type (2016-2027) Figure 25. Europe Melanoma Cancer Market Share by Application (2016-2027) Figure 26. Europe Melanoma Cancer Market Share by Country (2016-2027) Figure 27. Germany Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. France Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. U.K. Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Italy Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Russia Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Nordic Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Asia-Pacific Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Melanoma Cancer Market Share by Type (2016-2027) Figure 35. Asia-Pacific Melanoma Cancer Market Share by Application (2016-2027) Figure 36. Asia-Pacific Melanoma Cancer Market Share by Region (2016-2027) Figure 37. China Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Japan Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. South Korea Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Southeast Asia Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. India Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Australia Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Latin America Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Melanoma Cancer Market Share by Type (2016-2027) Figure 45. Latin America Melanoma Cancer Market Share by Application (2016-2027) Figure 46. Latin America Melanoma Cancer Market Share by Country (2016-2027) Figure 47. Mexico Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Brazil Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Middle East & Africa Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Melanoma Cancer Market Share by Type (2016-2027) Figure 51. Middle East & Africa Melanoma Cancer Market Share by Application (2016-2027) Figure 52. Middle East & Africa Melanoma Cancer Market Share by Country (2016-2027) Figure 53. Turkey Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Saudi Arabia Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. UAE Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. AB Sciences Revenue Growth Rate in Melanoma Cancer Business (2016-2021) Figure 57. Incyte Revenue Growth Rate in Melanoma Cancer Business (2016-2021) Figure 58. Merck Revenue Growth Rate in Melanoma Cancer Business (2016-2021) Figure 59. Novartis Revenue Growth Rate in Melanoma Cancer Business (2016-2021) Figure 60. Pierre Fabre Revenue Growth Rate in Melanoma Cancer Business (2016-2021) Figure 61. Amgen Revenue Growth Rate in Melanoma Cancer Business (2016-2021) Figure 62. AstraZeneca Revenue Growth Rate in Melanoma Cancer Business (2016-2021) Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Cancer Business (2016-2021) Figure 64. Daiichi Sankyo Revenue Growth Rate in Melanoma Cancer Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

AB Sciences Incyte Merck Novartis Pierre Fabre Amgen AstraZeneca Bristol-Myers Squibb Daiichi Sankyo